CN Patent

CN103458877B — 免疫抑制性制剂

Assigned to Novartis AG · Expires 2016-06-08 · 10y expired

What this patent protects

本发明涉及包含一种或多种药学上可接受的赋形剂及活性药物成分(“API”)的固相药物组合物，该活性药物成分是式A1或A2的化合物或其药学上可接受的盐、溶剂化物或水合物，其中该API不暴露于碱性化合物。

USPTO Abstract

本发明涉及包含一种或多种药学上可接受的赋形剂及活性药物成分(“API”)的固相药物组合物，该活性药物成分是式A1或A2的化合物或其药学上可接受的盐、溶剂化物或水合物，其中该API不暴露于碱性化合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN103458877B
Jurisdiction
CN
Classification
—
Expires
2016-06-08
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.